$285 Million is the total value of Endurant Capital Management LP's 50 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 81.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INVACARE CORPnote 5.000%11/1 | $50,011,000 | -0.4% | 56,727,000 | 0.0% | 17.54% | +32.7% | ||
| QGEN | Buy | QIAGEN NV | $18,796,000 | +589.3% | 398,221 | +615.5% | 6.59% | +818.4% |
| BSX | New | BOSTON SCIENTIFIC CORP | $15,585,000 | – | 418,165 | +100.0% | 5.47% | – |
| AVTR | Buy | AVANTOR INC | $14,021,000 | +45.0% | 450,821 | +57.7% | 4.92% | +93.1% |
| HUM | Sell | HUMANA INC | $12,688,000 | +0.1% | 27,106 | -6.9% | 4.45% | +33.3% |
| ICLR | New | ICON PLC | $10,774,000 | – | 49,718 | +100.0% | 3.78% | – |
| CI | Buy | CIGNA CORP NEW | $10,639,000 | +54.6% | 40,372 | +40.6% | 3.73% | +105.8% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $9,771,000 | -78.8% | 25,900 | -74.6% | 3.43% | -71.7% |
| XBI | SPDR SER TRcall | $9,358,000 | +726.7% | 126,000 | 0.0% | 3.28% | +1001.7% | |
| INVACARE CORPnote 5.000%11/1 | $9,249,000 | -2.9% | 10,097,000 | 0.0% | 3.24% | +29.4% | ||
| HOLX | Buy | HOLOGIC INC | $8,847,000 | -6.8% | 127,656 | +3.3% | 3.10% | +24.1% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $8,137,000 | -49.6% | 34,718 | -43.3% | 2.86% | -32.9% |
| AZYO | Buy | AZIYO BIOLOGICS INC | $8,012,000 | +21.4% | 1,133,183 | +2.1% | 2.81% | +61.6% |
| BIO | Sell | BIO RAD LABS INCcl a | $7,934,000 | -17.9% | 16,028 | -6.5% | 2.78% | +9.4% |
| ZTS | New | ZOETIS INCcl a | $7,065,000 | – | 41,100 | +100.0% | 2.48% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $6,041,000 | +42.3% | 4,611,635 | +33.6% | 2.12% | +89.4% |
| SGEN | New | SEAGEN INC | $5,816,000 | – | 32,871 | +100.0% | 2.04% | – |
| CNC | Sell | CENTENE CORP DEL | $5,779,000 | -68.5% | 68,305 | -68.7% | 2.03% | -58.1% |
| BAX | New | BAXTER INTL INC | $5,772,000 | – | 89,863 | +100.0% | 2.02% | – |
| SIBN | Buy | SI-BONE INC | $5,678,000 | -39.2% | 430,159 | +4.1% | 1.99% | -19.1% |
| MCK | Sell | MCKESSON CORP | $5,214,000 | -41.6% | 15,984 | -45.2% | 1.83% | -22.2% |
| QQQ | New | INVESCO QQQ TRput | $3,728,000 | – | 13,300 | +100.0% | 1.31% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $3,458,000 | – | 459,829 | +100.0% | 1.21% | – |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $3,101,000 | -30.3% | 1,824,065 | -15.6% | 1.09% | -7.2% |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $3,056,000 | -33.2% | 760,228 | -17.7% | 1.07% | -11.0% |
| GLPG | Sell | GALAPAGOS NVspon adr | $2,869,000 | -11.7% | 51,410 | -1.9% | 1.01% | +17.5% |
| INSM | Sell | INSMED INC | $2,802,000 | -27.9% | 142,071 | -14.0% | 0.98% | -3.9% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $2,729,000 | – | 27,992 | +100.0% | 0.96% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $2,588,000 | +72.8% | 81,007 | +87.3% | 0.91% | +129.9% |
| THC | Sell | TENET HEALTHCARE CORP | $2,494,000 | -77.9% | 47,442 | -63.9% | 0.88% | -70.6% |
| INCY | New | INCYTE CORP | $2,371,000 | – | 31,211 | +100.0% | 0.83% | – |
| XBI | Sell | SPDR SER TRs&p biotech | $2,328,000 | -44.2% | 31,349 | -32.5% | 0.82% | -25.7% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $2,153,000 | – | 25,975 | +100.0% | 0.76% | – |
| DXCM | New | DEXCOM INC | $1,941,000 | – | 26,046 | +100.0% | 0.68% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $1,862,000 | -23.6% | 357,465 | +20.6% | 0.65% | +1.7% |
| FATE | Buy | FATE THERAPEUTICS INC | $1,775,000 | -23.4% | 71,640 | +19.9% | 0.62% | +2.1% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $1,641,000 | +34.5% | 64,756 | +67.5% | 0.58% | +79.4% |
| ABC | New | AMERISOURCEBERGEN CORP | $1,629,000 | – | 11,515 | +100.0% | 0.57% | – |
| MMSI | New | MERIT MED SYS INC | $1,098,000 | – | 20,223 | +100.0% | 0.38% | – |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $1,095,000 | – | 16,189 | +100.0% | 0.38% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $1,045,000 | – | 9,949 | +100.0% | 0.37% | – |
| ALBO | Sell | ALBIREO PHARMA INC | $751,000 | -79.2% | 37,835 | -68.7% | 0.26% | -72.3% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $674,000 | – | 8,454 | +100.0% | 0.24% | – |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $654,000 | – | 23,015 | +100.0% | 0.23% | – |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $584,000 | -85.9% | 15,246 | -84.8% | 0.20% | -81.2% |
| ADCT | New | ADC THERAPEUTICS SA | $469,000 | – | 58,967 | +100.0% | 0.16% | – |
| CYTK | New | CYTOKINETICS INC | $453,000 | – | 11,538 | +100.0% | 0.16% | – |
| BDSX | BIODESIX INC | $214,000 | -3.2% | 130,753 | 0.0% | 0.08% | +29.3% | |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $194,000 | -76.1% | 79,097 | -0.4% | 0.07% | -68.2% |
| IMUX | Sell | IMMUNIC INC | $106,000 | -92.8% | 30,591 | -76.6% | 0.04% | -90.5% |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -243,795 | -100.0% | -0.08% | – |
| Exit | DARIOHEALTH CORP | $0 | – | -73,779 | -100.0% | -0.11% | – | |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -68,710 | -100.0% | -0.16% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -3,308 | -100.0% | -0.25% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -59,474 | -100.0% | -0.26% | – |
| NTRA | Exit | NATERA INC | $0 | – | -24,747 | -100.0% | -0.26% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -60,720 | -100.0% | -0.27% | – |
| CDNA | Exit | CAREDX INC | $0 | – | -28,048 | -100.0% | -0.27% | – |
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -314,238 | -100.0% | -0.29% | – |
| DVA | Exit | DAVITA INCput | $0 | – | -10,000 | -100.0% | -0.30% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -105,792 | -100.0% | -0.32% | – |
| ICUI | Exit | ICU MED INC | $0 | – | -6,093 | -100.0% | -0.36% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -4,480 | -100.0% | -0.37% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -83,217 | -100.0% | -0.40% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -354,492 | -100.0% | -0.41% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -10,379 | -100.0% | -0.45% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -6,982 | -100.0% | -0.48% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -15,400 | -100.0% | -0.48% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -24,923 | -100.0% | -0.50% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -15,342 | -100.0% | -0.51% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -18,236 | -100.0% | -0.56% | – |
| MTD | Exit | METTLER TOLEDO INTERNATIONAL | $0 | – | -1,765 | -100.0% | -0.64% | – |
| PINC | Exit | PREMIER INCcl a | $0 | – | -75,632 | -100.0% | -0.71% | – |
| IDXX | Exit | IDEXX LABS INC | $0 | – | -5,729 | -100.0% | -0.83% | – |
| AHCO | Exit | ADAPTHEALTH CORP | $0 | – | -248,314 | -100.0% | -1.05% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -65,653 | -100.0% | -1.23% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -17,232 | -100.0% | -1.37% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -44,561 | -100.0% | -1.38% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -123,232 | -100.0% | -2.63% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -194,684 | -100.0% | -3.74% | – |
| OFIX | Exit | ORTHOFIX MED INC | $0 | – | -434,803 | -100.0% | -3.74% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -240,271 | -100.0% | -4.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.